References
- Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682
- Mitchell RM, Byrne MF, Baillie J. Pancreatitis [review]. Lancet 2003; 361: 1447
- Hamlyn AN, Brown AJ, Sherlock S, Baron DN. Casual blood-ethanol estimations in patients with chronic liver disease. Lancet 1975; 2: 345
- Jaakkola M, Frey T, Sillanaukee P, Koivula T, Nordback I. Acute pancreatic injury in asymptomatic individuals after heavy drinking over the long-term. Hepato-Gastroenterol 1994; 41: 477
- Nordback I, Jaakkola M, Iovanna JL, Dagorn JC. Increased serum pancreatitis associated protein (PAP) concentration after long-term alcohol consumption: further evidence for regular subclinical pancreatic damage after heavy drinking?. Gut 1995; 36: 117
- Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): A review of recent research. Alcohol Clin Exp Res 2002; 2: 272
- Jaakkola M, Sillanaukee P, Löf K, Koivula T, Nordback I. Blood tests for detection of alcoholic cause of acute pancreatitis. Lancet 1994; 343: 1328
- Jaakkola M, Sillanaukee P, Löf K, Koivula T, Nordback I. Amount of alcohol is an important determinant of the severity of acute alcoholic pancreatitis. Surgery 1994; 115: 31
- Goldstein DB. Pharmacological aspects of physical dependence on ethanol [review]. Life Sci 1976; 18: 553
- Nordback IH, MacGowan S, Potter JJ, Cameron JL. The role of acetaldehyde in the pathogenesis of acute alcoholic pancreatitis. Ann Surg 1991; 214: 671
- He ZJ, Ericksson P, Alho H, Harmoinen A, Nordback I. Effects on endogenous acetaldehyde production by disulfiram and ethanol feeding on rat pancreas. J Gastrointest Surg 2001; 5: 531
- Whitcomb DC. Genetic predisposition to alcoholic chronic pancreatitis. Pancreas 2003; 27: 321
- Cook RT. Alcohol abuse, alcoholism and damage to the immune system [review]. Alcohol Clin Exp 1998; 22: 1927
- Mandrekar P, Dolganiuc A, Bellerose G, Kodys K, Romics L, Nizamani R, et al. Acute alcohol inhibits the induction of nuclear regulatory factor (kappa)B activation through CD14/Toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory (kappa)B(alpha) degradation?. Alcohol Clin Exp 2002; 26: 1609